Advancing Artificial Intelligence for Medicine and Genetics

Ronak Y. Patel is a scientist, innovator, and leader in genomics and bioinformatics with a proven track record of building impactful resources that advance precision medicine. With more than a decade of experience in academic research and leadership, he has transformed complex genetic and biomedical data into accessible, widely adopted tools for clinicians and researchers worldwide.

As an Assistant Professor at Baylor College of Medicine, Ronak led the development of several key platforms under the NIH-funded Clinical Genome (ClinGen) project, including the ClinGen Allele Registry, Pathogenicity Calculator, Evidence Repository, and Actionability Curation Interface. These resources—now used by thousands of clinicians and scientists globally—have solved long-standing challenges in genetic variant interpretation and data sharing. Notably, his contributions include two resources that became part of the first FDA-approved genetic variant database, a milestone in clinical genomics.

Earlier in his career, Ronak pioneered computational methods at Washington University in St. Louis and the University of Mississippi, applying bioinformatics, structural biology, and machine learning to advance drug discovery and transcription factor analysis. His research has been published in top-tier journals such as Science, Cell, Genome Medicine, and The American Journal of Human Genetics, with over 30 publications and significant citations reflecting his impact in the field. His work has also attracted attention from the FDA, NIH, and international genomic consortia, underscoring its global relevance.

An educator and mentor, Ronak has co-directed courses in bioinformatics and genome analysis, earning top ratings from students for his innovative teaching style. His entrepreneurial mindset has been evident throughout his career—whether in building tools adopted by global communities, creating licensing and revenue opportunities from bioinformatics platforms, or driving international collaborations in genomics.

As the founder of Nucleati, Ronak brings together deep scientific expertise, a passion for technology-driven solutions, and a vision to accelerate discovery and translation in healthcare. His mission is to bridge the gap between cutting-edge genomic science and real-world clinical applications, empowering researchers, clinicians, and patients alike.

Business Transformation Leader | Agile Strategist | Entrepreneurial Innovator

Shridhan Kasa is an accomplished business and technology leader with more than two decades of experience driving transformation across IT, healthcare, life sciences, pharmaceuticals, banking, education, and retail. Throughout his career, he has consistently bridged the gap between business strategy and technology execution, helping organizations unlock growth, efficiency, and innovation.

As a Certified Scrum Master, leadership program graduate from Harvard, and a dual MBA holder, Shridhan has successfully guided enterprises and government agencies through large-scale digital transformations. At Millipore Sigma, he has been instrumental in building enterprise-level Agile teams, coaching cross-functional leaders, and delivering high-impact eCommerce and B2B initiatives. His ability to align complex technology programs with business goals has resulted in measurable improvements in speed-to-market, customer engagement, and operational efficiency.

Beyond Agile transformation, Shridhan brings a strong foundation in business strategy, market development, and entrepreneurship. He has led multimillion-dollar product launches, spearheaded business expansions into new territories, and developed brand strategies that positioned companies for long-term growth. Earlier in his career, he drove sales and marketing success at global healthcare and diagnostic companies, where he managed distributor networks, established high-value partnerships, and delivered consistent revenue growth in competitive markets.

Shridhan is widely recognized for his ability to build and inspire teams, foster collaboration across global stakeholders, and navigate complex business environments with discipline and vision. His expertise spans business process reengineering, regulatory compliance (HIPAA, CMS, Sunshine Act), government program modernization, and large-scale program delivery for both public and private sector organizations.

With an entrepreneurial mindset, Shridhan approaches every challenge as an opportunity to innovate. He has led startups, established new IT departments from the ground up, and advised leadership teams on scaling operations and digital ecosystems. His strategic insight, combined with hands-on execution, makes him a trusted advisor and results-driven leader.

Today, Shridhan continues to bring together the disciplines of business management, technology, and Agile leadership to help organizations adapt, grow, and thrive in rapidly changing markets.

Rohini Sidhu brings more than 15 years of specialized experience in bioanalysis and biomarker research. Currently, she contributes her expertise to Novo Nordisk, focusing on nonclinical and Phase 1 clinical studies. Her strong background in scientific project management and laboratory operations enhances her ability to drive successful outcomes in complex research environments.

Rohini's previous position at Washington University in St. Louis allowed her to significantly impact the field by developing diagnostic biomarkers and newborn screening tests for NPC1 disease.

Outside of her professional commitments, Rohini actively engages with the scientific community through consulting, sharing her knowledge and insights to promote advancements in the field. She has authored over 40 peer-reviewed articles, which highlight her dedication to research excellence and can be accessed via her google scholar profile: Rohini Sidhu - Google Scholar

Dr. Patel is an Associate Professor and board certified pediatric pathologist with over 15 years of clinical experience. She led the informatics and Digital Pathology efforts at Texas Children's Hospital in Houston and now serves as the Medical Director of Digital Pathology and AI at Cincinnati Children's Hospital. She uses Adenine AI for variant assessment in pediatric cholestatic disorders.